Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal doxorubicin cooperative study in recurrent ovarian cancer
ChiCTR-ONC-13003650Phase 4Completed
- Sponsor
- Shandong Cancer Hospital
- Start
- Oct 2013
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pegylated liposomal doxorubicin in ovarian cancer, sponsored by Shandong Cancer Hospital. Primary endpoint: CA125. Started Oct 2013; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on ChiCTR-ONC-13003650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003650.